-

Berkley Lights, Inc. Shareholders: Robbins LLP Informs Investors that Berkeley Lights, Inc. (BLI) is Being Sued by Shareholders

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased Berkeley Lights, Inc. (NASDAQ: BLI) common stock between July 17, 2020 and September 14, 2021. The complaint alleges violations of the Securities Exchange Act of 1934.

If you purchased Berkeley Lights, Inc. (BLI) common stock between July 17, 2020 and September 15, 2021, you have until February 7, 2022, to ask the court to appoint you lead plaintiff for the class.

If you suffered a loss due to Berkeley Lights's misconduct, click here.

Berkeley Lights, Inc. (BLI) Misled Investors Regarding its Business Prospects

According to the complaint, Berkeley Lights conducted its initial public offering (IPO) in July 2020. Leading up to the IPO, Berkeley Lights claimed to be experiencing revenue growth with its direct platform sales. This trend purportedly continued after the IPO, as Berkeley Lights stated it continued to experience year-over-year increases in its direct platform sales revenue in its financial results for the second and third quarters of 2020. During this time, the price of Berkeley Lights common stock quadrupled from the IPO price, reaching over $90 per share on November 12, 2020. In November 2020, the Company filed its prospectus for a secondary public offering ("SPO"), touting its product offerings as "the most advanced" and "not attainable with other approaches." After the SPO, Berkeley Lights highlighted is increased revenue for the quarter and fiscal year ended December 31, 2020.

However, these statements were false. Berkeley Lights' flagship instrument suffered from design and manufacturing defects, Berkeley had received numerous customer complaints regarding the durability and effectiveness of the Company's automation systems, and the actual market for the Company's products and services was a fraction of the $23 million it had represented to investors. On September 15, 2021, research analyst firm Scorpion Capital issued a report criticizing Berkeley Lights' technology and questioned the durability of the Company's most important business relationships and its business growth plan. On this news, the Company's stock fell nearly 30% over two trading days, to close at $23.53 on September 16, 2021.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:
Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com

Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Berkeley Lights, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Robbins LLP Urges ZoomInfo Technologies Inc. Stockholders to Contact the Firm for Information About the Class Action Against GTM  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ZoomInfo Technologies Inc. (NASDAQ: GTM) securities between November 3, 2025 and May 11, 2026. ZoomInfo Technologies Inc., together with its subsidiaries, provides go-to-market intelligence and engagement platform for sales, marketing, operations, and recruiting professionals in the United States and internationally.For more information, submit...

Erasca, Inc. Class Action Reminder - Robbins LLP Encourages ERAS Stockholders to Contact the Firm for Information About Their Rights  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Erasca, Inc. (NASDAQ: ERAS) securities between January 14, 2025 and April 26, 2026. Erasca, Inc., a clinical-stage precision oncology company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call...

ADMA Biologics, Inc. Stock Drop: Robbins LLP Urges Investors to Contact the Firm for Information About the Class Action Against ADMA Biologics, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. (NASDAQ: ADMA) securities between August 9, 2024 and March 25, 2026. ADMA Biologics, Inc. is a biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. For more information...
Back to Newsroom